PAŘENICA, Jiří, Petr KALA, Alexandre MEBAZAA, Simona LITTNEROVÁ, Klára BENEŠOVÁ, Josef TOMANDL, Monika PÁVKOVÁ GOLDBERGOVÁ, Jiří JARKOVSKÝ, Jindřich ŠPINAR, Marie TOMANDLOVÁ, Milan DASTYCH, Can INCE, Kateřina HELÁNOVÁ, Martin TESÁK, Martin HELÁN, Petr LOKAJ and Matthieu LEGRAND. Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury. CARDIORENAL MEDICINE. BASEL: KARGER, 2020, vol. 10, No 2, p. 85-96. ISSN 1664-3828. Available from: https://dx.doi.org/10.1159/000503718.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury
Authors PAŘENICA, Jiří (203 Czech Republic, belonging to the institution), Petr KALA (203 Czech Republic, belonging to the institution), Alexandre MEBAZAA (250 France), Simona LITTNEROVÁ (203 Czech Republic, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), Josef TOMANDL (203 Czech Republic, belonging to the institution), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Jindřich ŠPINAR (203 Czech Republic, belonging to the institution), Marie TOMANDLOVÁ (203 Czech Republic, belonging to the institution), Milan DASTYCH (203 Czech Republic, belonging to the institution), Can INCE (528 Netherlands), Kateřina HELÁNOVÁ (203 Czech Republic, belonging to the institution), Martin TESÁK (203 Czech Republic, belonging to the institution), Martin HELÁN (203 Czech Republic, belonging to the institution), Petr LOKAJ (203 Czech Republic, belonging to the institution) and Matthieu LEGRAND (250 France, guarantor).
Edition CARDIORENAL MEDICINE, BASEL, KARGER, 2020, 1664-3828.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.041
RIV identification code RIV/00216224:14110/20:00115794
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1159/000503718
UT WoS 000526816300002
Keywords in English Acute kidney injury; Nitric oxide; Myocardial infarction; Oxidative stress; Cardio renal
Tags 14110122, 14110211, 14110512, 14110518, 14110616, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 31/8/2020 12:01.
Abstract
Background/Aims: The pathophysiology of acute kidney injury (AKI) in ST-elevation myocardial infarction (STEMI) patients remains poorly explored. The involvement of the nitric oxide (NO) pathway has been demonstrated in experimental ischemic AKI. The aim of this study was to assess the predictive value of circulating biomarkers of the NO pathway for AKI in STEMI patients. Methods: Four hundred and twenty-seven STEMI patients treated with primary percutaneous coronary intervention were included. The primary end point was AKI. Biomarkers of the NO pathway (plasma superoxide dismutase [SOD], uric acid, nitrite/nitrate [NOx], neopterin) as well as cardiac biomarkers (B-type natriuretic peptide [BNP] and troponin) were sampled 12 h after admission. The predictive value of circulating biomarkers was evaluated in addition to the multivariate clinical model. Results: AKI developed in 8.9% of patients. The 3-month mortality was significantly higher in patients with AKI (34.2 vs. 4.1%; p < 0.001). SOD, uric acid, NOx, neopterin, BNP and troponin were significantly associated with the development of AKI (area under curve [AUC]-receiver operating curve [ROC] ranging between 0.70 and 0.81). In multivariate analysis cardiogenic shock, neopterin, NOx and troponin were independent predictors of AKI. AUC-ROC of the association of multibiomarkers and clinical model was 0.90 and outperformed the predictive value of the clinical model alone. OR of NOx >= 45 mu mol/L was 8.0 (95% CI 3.1-20.6) for AKI. Conclusion: Biomarkers of the NO pathway are associated with the development of AKI in STEMI patients. These results provide insights into the pathophysiology of AKI and may serve at developing preventing strategies for AKI targeting this pathway.
Links
MUNI/A/1250/2017, interní kód MUName: Validace Rule-out/rule-in protokolu u pacientů s bolestí na hrudi – pokračování v prospektivní studii
Investor: Masaryk University, Category A
PrintDisplayed: 13/7/2024 17:06